Skip to main content

SureMASTR BRCA Screen Newsitem

Agilent Technologies is proud to introduce, SureMASTR BRCA Screen, a new member of the amplicon-based BRCA solutions. SureMASTR BRCA Screen, in combination with the MASTR Reporter data analysis software, is a molecular research solution for the detection of variants in BRCA1, BRCA2, CHEK2, and PALB2. The single primer-pool means an even easier and improved workflow, and the solution is suited for both germline and somatic applications. MASTR Reporter software allows you, on top of variant analysis, to monitor and trace the quality of your results and manage the entire workflow of your laboratory.

Key benefits:

  • Unique assay design for variant detection in BRCA1, BRCA2, CHEK2 and PALB2
  • Reliable variant analysis: SNVs, Indels and CNVs simultaneously
  • Flexible assay thanks to assay compatibility with various Illumina NGS systems (MiSeq, MiniSeq, NextSeq)
  • Fast and accurate results thanks to exclusive single primer-pool workflow
  • Easy-to use and comprehensive data analysis tool (MASTR Reporter)

Find out more details here!


Ordering details:

MR-1360.024

SureMASTR BRCA Screen + MASTR Reporter

Breast, Ovarian and other Cancers


For Research Use Only. Not for use in diagnostic procedures.